Guggenheim Maintains Buy on Acadia Healthcare Co, Raises Price Target to $31

Benzinga Newsdesk www.benzinga.com Positive 84.4%

Neg 0% Neu 0% Pos 84.4%

Guggenheim analyst Jason Cassorla maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and raises the price target from $26 to $31.